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Antiphospholipid syndrome (APS) is one of several prothrombotic states in
which thrombi occur within both the venous and arterial beds. A minority of
patients with APS present with an acute and devastating syndrome character-
ized by multiple simultaneous vascular occlusions throughout the body. “Cat-
astrophic APS” is defined by the clinical involvement of at least three different
organ systems over a period of days or weeks with histological evidence of
multiple occlusions of large or small vessels. We report the case of a 16-year-
old girl referred to our paediatric cardiology unit for NHYA IV and a blowing
systolic murmur at the apex radiating to the left axilla. Transthoracic echocar-
diography (TTE) revealed mitral valve leaflet thickening with vegetations
(13 mm) on the edges of both leaflets and moderate mitral regurgitation (MR)
(image 1). The diagnosis of Libman-Sacks or non-bacterial thrombotic
endocarditis secondary to antiphospholipid syndrome was suggested by
repeated negative blood cultures along with persistently elevated anticardio-
lipin antibody titers. The condition deteriorated to acute thrombotic microan-
giopathy affecting multiple organs with arterial hypertension and
thrombocytopenia. Anticoagulation with warfarin was peformed and aspirin,
corticosteroids and ACE inhibitors were given. TTE follow-up after 1.5 years
revealed no recurrence of MR with normal mitral valve leaflets. 
Conclusion: In catastrophic APS an aggressive therapeutic approach is war-
ranted. Valve lesions may become more severe during long term follow-up.
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Peak systolic Doppler velocity at the aortic isthmus alone is not a good pre-
dictor of severity in patients with native or residual coarctation (CoA). A
major argument in favour of a hemodynamically significant CoA is the pres-
ence of a diastolic gradient (DG) with characteristic “sawtooth” appearance of
the Doppler pattern. 
Aim of the study: to evaluate, in patients with some degree of aortic
isthmus narrowing but without significant DG at rest, if exercise could unmask
DG and thus hemodynamically significant CoA. 
Material and methods: Fourteen patients aged from 12 to 56 years under-
went treadmill exercise testing coupled with Doppler echocardiography. Thir-
teen had previous CoA repair 8 to 43 years before, one had aortic kinking with
mild isthmic narrowing on CT-scan. MRI or CT-scan were performed in
11 patients, showing significant residual stenosis (narrowing >30%) in 8/11.
Doppler measurements were performed during exercise testing and 5 minutes
after at the suprasternal notch, using a CW-Doppler 2 MHz pedoff probe. The
peak systolic and diastolic gradients through aortic isthmus were measured at
rest and at the end of the exercise. A peak DG > 17 mmHg was considered
significant.
Results: Mean peak systolic gradient increased from 29 to 65 mmHg with
exercise. Significant DG appeared in 4 of 8 patients without any DG at rest.
Among the 6 patients with non significant DG at rest, DG remained non sig-
nificant in 2 and became significant in 4. For the 11 patients with MRI or CT-
scan aortic arch evaluation, the specificity of significant DG at exercise was
100%, the sensitivity 75%, predictive positive value 100%, negative predictive
value 60%.
Conclusion: Apparition of a significant isthmic Doppler DG at exercise
can reliably predict the hemodynamic significance of restenosis after CoA
repair, as well as native narrowing of the aorta. This simple, safe and effective
non-invasive method may help to identify patients requiring surgery or percu-
taneous stenting.
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Introduction: Levosimendan (Lev) is a new calcium sensitizer and K-ATP
channel opener. The documentation regarding this drug is one of the largest
ever on the safety and efficacy of a new pharmacological agent in acute heart
failure syndromes in adult population. Its use in paediatric is limited to suc-
cessful weaning from biventricular mechanical support in case reports or small
trials conducted in the immediate postoperative period. We report our experi-
ence of using (Lev) during refractory cardiogenic shock (RCS) in infants. 
Patients and Methods: Four infants aged 2-24 months and suffering from
hypokinetic dilated cardiomyopathy) were included in this study. All presented
with uncontrolled RCS (LVEF <20%) despite conventional inotropes treat-
ment. Lev was intended as a last resort before ECMO. The effectiveness of
treatment was monitored by measuring the echocardiographic left ventricular
ejection fraction (LVEF) and plasma BNP assay before and 8 days after
administration. A total of 15 injections of Lev were realized and studied.
Results: Mean LVEF before and 8 days after administration of Lev signif-
icantly increase from 19.75 % +/- 1.7 to 33 +/- 2.95 (p<0.01) and mean BNP
level decrease from 2267 pg/ml +/- 518 to 1673 +/- 372 (p<0.08). These chil-
dren could benefit from additional treatments of Lev in order to wean amines
and defer the circulatory support. In one of these, a total of 6 cycles was nec-
essary without the use of circulatory support for an improvement. In the
4 patients studied, the outcome was favorable. Figure 1 illustrates the indi-
vidual changes in LVEF and BNP after each Lev injection.
Conclusion: During the refractory cardiogenic shock of the child with
hypokinetic dilated cardiomyopathy, levosimendan may improve myocardial
function allowing weaning of conventional inotropes and circulatory support.
Re-injection may also be necessary. Randomized studies with larger number
of patients are needed to confirm these very encouraging results. 
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Introduction and objectives: Percutaneous closure of patent ductus arteri-
osus (PDA) is a well-established technique. We evaluated the usefulness of the
Amplatzer duct occluder (ADO) for the percutaneous closure of large patent
ductus arteriosus in 16 children less than 2 years of age.
